Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 29.45B | 27.58B | 24.62B | 31.32B | 28.58B |
Gross Profit | 2.55B | 2.43B | 2.23B | 3.27B | 3.36B |
EBITDA | 1.17B | 1.14B | 921.00M | 2.00B | 2.10B |
Net Income | 921.00M | 685.00M | 523.00M | 1.25B | 1.32B |
Balance Sheet | |||||
Total Assets | 25.30B | 27.39B | 23.78B | 25.41B | 23.60B |
Cash, Cash Equivalents and Short-Term Investments | 4.48B | 9.57B | 9.43B | 9.18B | 7.73B |
Total Debt | 831.00M | 827.00M | 831.00M | 821.00M | 929.00M |
Total Liabilities | 10.40B | 13.03B | 9.72B | 11.45B | 10.45B |
Stockholders Equity | 14.90B | 14.36B | 14.06B | 13.97B | 13.14B |
Cash Flow | |||||
Free Cash Flow | -4.45B | 617.00M | 711.00M | 2.02B | -325.00M |
Operating Cash Flow | -4.23B | 680.00M | 799.00M | 2.10B | -228.00M |
Investing Cash Flow | -407.00M | -70.00M | -80.00M | -78.00M | -74.00M |
Financing Cash Flow | -466.00M | -468.00M | -468.00M | -569.00M | -474.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥8.78B | 5.27 | 0.25% | 15.97% | 3.62% | ||
80 Outperform | ¥10.75B | 5.66 | 0.27% | 23.15% | 46.68% | ||
77 Outperform | ¥11.68B | 4.40 | 4.37% | 11.12% | 29.82% | ||
75 Outperform | ¥10.11B | 11.88 | 4.76% | 5.27% | -26.42% | ||
72 Outperform | ¥10.22B | 11.09 | 4.49% | 6.79% | 34.45% | ||
67 Neutral | £2.85B | 10.49 | 4.46% | 3.55% | 2.44% | -20.00% | |
63 Neutral | ¥9.32B | 4.26 | 2.48% | 18.22% | 430.92% |